ARTICLE

FindCenter AddIcon

Seismic Sisters: Fighting Stigma of Psychedelics with Science - An Interview with Natalie Ginsberg, Policy and Advocacy Director at Multidisciplinary Association for Psychedelic Studies

By Jessica Semaan — 2020

Society has started to become more accepting of our work and MAPS’ goal of mainstreaming psychedelic medicine seems closer than ever to being achieved,” explains MAPS Policy and Advocacy Director Natalie Ginsberg, M.S.W., in an interview with Jessica Semaan of Seismic Sisters. During the interview, Ginsberg shares her perspectives about the shift in acceptance towards the therapeutic potential of psychedelics, expresses her passion for drug policy, and explains what led her to work at MAPS.

Read on maps.org

FindCenter Post-Image

Psilocybin Sessions: Psychedelics Could Help People with Addiction and Anxiety

Study participants at some of the country's leading medical research centers are going through intense therapy and six-hour psychedelic journeys deep into their minds to do things like quit smoking and worry less.

Article
Anderson Cooper
2019
FindCenter AddIcon
FindCenter Post-Image

LSD May Cure Some Addicts

Psychedelic drugs are making a quiet comeback, as a smattering of recent studies have demonstrated their medicinal potential. The latest finding suggests it is time to revisit LSD as a treatment for addiction.

Article
Ian Chant
2012
FindCenter AddIcon
FindCenter Post-Image

Largest Ever Psychedelics Study Maps Changes of Conscious Awareness to Neurotransmitter Systems

In the world’s largest study on psychedelics and the brain, a team of researchers from The Neuro (Montreal Neurological Institute-Hospital) and Department of Biomedical Engineering of McGill University, the Broad Institute at Harvard/MIT, SUNY Downstate Health Sciences University, and Mila—Quebec...

Article
Neuroscience News
2022
FindCenter AddIcon
FindCenter Post-Image

Scientists Show How LSD Blows Open the Doors of Perception

The drug lowers brain barriers, allowing distant regions to talk and thoughts to flow more freely.

Article
Ben Turner
2021
FindCenter AddIcon
FindCenter Post-Image

An Introduction to Psilocybin

With the advent of the psychedelic renaissance occurring currently, many people have become curious about one of the most famous hallucinogens: psilocybin mushrooms. Read on to discover the most important information about these fascinating fungi.

Article
FindCenter
2022
FindCenter AddIcon
FindCenter Post-Image

It’s Time to Start Studying the Downside of Psychedelics

Before psychedelic therapy and services becomes widely available, there needs to be a better understanding of all the ways these experiences can go wrong.

Article
Shayla Love
2022
FindCenter AddIcon
FindCenter Post-Image

FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

Article
Yasemin Saplakoglu
2019
FindCenter AddIcon
FindCenter Post-Image

Ketamine Therapy Is Going Mainstream. Are We Ready?

The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.

Article
Emily Witt
2021
FindCenter AddIcon
FindCenter Post-Image

What Psychedelic Mushrooms Are Teaching Us About Human Consciousness

Psychedelic drugs like psilocybin are being tested to treat mental illness. They're also expanding our understanding about human consciousness.

Article
Iris Kulbatski
2020
FindCenter AddIcon
FindCenter Post-Image

Study with Ravers Suggests Psychedelics Linked to Social Bonding and Prosocial Behaviours

New research from Kent has identified prosocial behaviours and bonding amongst people who attend raves, which may help explain why rave culture has endured for the last thirty years.

Article
Olivia Miller
2021
FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research